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Interaction of immune complexes with glomerular heparan
sulfate—proteoglycans. The binding characteristics of cationic and more
neutral immune complexes with heparan sulfate—proteoglycan enriched
anionic sites of glomerular basement membrane and mesangial matrix
were studied. Rat kidneys were treated either with buffers alone or
buffers containing heparitinase or chondroitinase-ABC followed by
perfusion with cationic or native immune complexes. Tissues were
processed for immunofluorescence and transmission electron micros-
copy after fixation with glutaraldehyde or tannic acid glutaraldehyde.
Kidneys perfused with radioiodinated immune complexes were proc-
essed for light and electron microscopic autoradiography. In addition,
glomeruli from kidneys perfused with radioiodinated immune com-
plexes were isolated and counted for radioactivity. By immunofluores-
cence the cationic immune complexes deposited linearly along the
glomerular basement membrane. By electron microscopy, the cationic
complexes localized mainly in the inner and outer layers of the
glomerular basement membrane and to a certain extent in the mesangial
matrix in a distribution that corresponded to previously documented
anionic sites. Whereas heparitinase treatment abrogated the binding of
cationic immune complexes in both glomerular basement membrane
and mesangial matrix, chondroitinase-ABC treatment did not cause any
decrease in binding. In contrast, more neutral immune complexes
appeared to be nonspecifically trapped in the mesangium, and their
distribution was unaffected by both enzymatic treatments. Light and
electron microscopic autoradiography and counts of isolated glomeruli
confirmed these findings. The results overall indicate that cationic
immune complexes bind electrostatically to the heparan sulfate—
proteoglycan enriched anionic sites of the glomerular basement mem-
brane and mesangial matrix, while more neutral immune complexes are
nonspecifically trapped in the mesangium of the renal glomerulus.
Since the discovery of fixed anionic sites [1—4] in the base-
ment membrane (GBM)1 of the renal glomerular capillary wall,
the notion that these sites may be responsible for trapping
immune complexes or in situ immune complex formation has
attracted the attention of several investigators [5—15]. Evidence
that these sites are indeed involved has been gradually accu-
mulating. it is more or less established that cationic substances,
including immune complexes as well as free antigens or anti-
bodies, localize in the glomerular capillaries, specifically in the
'Abbreviations used in this paper are: BUG, bovine gamma globulin;
GBM, glomerular basement membrane; HS-PG, heparan sulfate—
proteoglycans.
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laminae rarae interna and externa of the GBM. On the other
hand, more neutral macromolecules, including immune com-
plexes, lodge nonspecifically in the mesangial regions of the
glomerulus. Immune complexes with both cationic antigen and
antibody have highly accentuated binding to GBM compared to
the mesangial matrix, whereas immune complexes with cationic
antigen or antibody alone may have somewhat different binding
characteristics depending upon the degree of cationization [5].
Thus, it seems that anionic sites play a significant role in the
trapping of immune complexes, most likely by ionic interaction
with the negatively—charged sulfate or carboxyl groups of some
of the acidic glycoproteins of the GBM. At least part of the
electronegativity of the anionic sites is due to the sulfate groups
of heparan sulfate—proteoglycans (HS-PU) [16, 17]. The HS-PG
of the GBM has a molecular weight of —130,000 with a core
protein (mol wt —18,000) to which 4-5 glycosaminoglycan
chains (mol wt —26,000) are attached [18, 19]. Such a molecular
structure for the HS-PG would form a highly intricate mesh-
work that would also endow the glomerular capillary wall with
a very high electronegative charge.
Although the tiltrastructural distribution of cationic immune
complexes and probes is similar [5, 8], until now it has remained
problematic whether the sulfate residues of HS-PG, a part of
the anionic sites, are the actual entrapment/binding regions for
cationic immune complexes. We have explored this possibility
in the present investigation, and the data indicate that the
sulfate residues of HS-PG do indeed bind cationic complexes in
both glomerular extracellular matrices, primarily the GBM and
to some extent the mesangial matrix. On the other hand, HS-PG
apparently plays a much less significant role in the nonspecific
lodging of neutral immune complexes in the mesangium.
Methods
Antigen and antibody
Two types of antigens were used, either native bovine gamma
globulin (BGG; Sigma Chemical Co., St. Louis, Missouri,
USA) or cationic BGG. Native BGG was further purified by
passage through Sephadex G-200 (Pharmacia Fine Chemicals,
Piscataway, New Jersey, USA) in 0.01 M phosphate buffered
saline, pH 7.2. The purified fraction was utilized as an antigen
for raising antibodies and also for preparing cationic BGG.
Rabbits were immunized with BGG in complete Freund's
adjuvant (Difco Laboratories, Detroit, Michigan, USA), and
their antisera obtained and decomplemented by heating at 56°C
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Fig. 1. Immunofluorescent micrographs of
glomeruli from kidneys perfused with
cationic (A, B, and C) or native (D, E, and
F) immune complexes after treatment with
buffer (A and D), chondroitinase-ABC (B
and E) or heparitinase (C and F). Fig. A
X 150; Figs. B—F x 400.
for 30 minutes. Anti-BGG IgG fraction was prepared by pre-
cipitation in half—saturated ammonium sulfate followed by
passage through a diethylaminoethyl (DEAE)-cellulose
(Schleicher and Schuell Inc., Keene, New Hampshire, USA)
column in 0.0175 M potassium phosphate, pH 6.30 [5]. Cationic
BGG was prepared by cationization of BGG by a two—step
reaction with ethylenediamine and carbodiimide [5, 20]. The
cationic BGG was then extensively dialyzed against normal
saline, lyophilized and dissolved in phosphate buffered saline,
pH 7.2.
Unlabelled immune complexes
Two types of soluble complexes were prepared as previously
described and characterized [5]: (a) native complexes, that is,
native heterogeneous BGG combined with native heteroge-
neous rabbit anti-BGG; and (b) cationic complexes, that is,
chemically modified cationic BGG (isoelectric point, p1, 9.5 to
11.5) combined with native heterogeneous rabbit anti-BGG.
The rabbit IgG fraction contained 11% of specific antibody
directed towards BOG. Based on quantitative immune precip-
itation to determine the equivalence point [21], immune com-
plexes were prepared in fivefold antigen excess at room tem-
perature, pH 7.2. Complexes were left overnight at 4°C and
centrifuged at 10,000 Xg for 10 minutes to remove any aggre-
gates before use. These differently charged complexes, which
are not distinguishable by size, extend over the range 9 to 25S
by sedimentation velocity [5].
Radioiodinated immune complexes
For preparation of radioiodinated immune complexes the
rabbit anti-BOG was conjugated with '251-iodine (Amersham
Co., Arlington Heights, Illinois, USA) by the lactoperoxi-
dase—glucose oxidase method [22, 23]. The iodinated product
was extensively dialyzed against normal saline to remove free
iodine and the protein concentration calculated by E2801 14.
Complexes were formed in the same manner as above. To
prepare cationic complexes, 59 mg of radioactive rabbit anti-
BGG containing 6.5 mg of specific antibody was added to 3.1
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mg of cationic BUG with constant stirring at room temperature.
For preparing more neutral heterogeneous complexes, 67 mg of
radioactive rabbit anti-BUG containing 7.4 mg of specific anti-
body was added to 2.2 mg of native BGG. The radioiodinated
complexes were centrifuged at 10,000 Xg for 10 minutes to
remove any aggregates.
Buffer and enzyme solutions
Approximately 1.0 mg of immune complexes, cationic or
native, was dissolved in 100 ml of Krebs Ringer bicarbonate
buffer containing 7.5% bovine serum albumin. This solution of
Fig. 2. Electron micrographs of glomeruli from
kidneys perfused with cationic immune complexes
after treatment with buffer (A), chondroitinase-ABC
(B) or heparitinase (C). Characteristically, cationic
immune complexes are seen as electron dense
deposits in the laminae rarae interna (LRI) and
externa (LRE) of the glomerular basement
membrane (GBM) and mesangial matrix (MM) as
indicated by arrows (A, B). After treatment with
heparitinase (C) the immune complexes no longer
bind to the anionic sites. Abbreviations are: fp, foot
processes; US, urinary space; En, endothelium;
Cap, capillary lumen; Ep, epithelium; Me,
mesangium. A x 60,000; B x 15,000; C >< 10,000.
immune complexes was used for binding studies in kidneys that
had been treated with glycosaminoglycan—degrading enzymes.
The enzyme solutions included chondroitinase-ABC (Miles
Laboratories, Naperville, Illinois, USA, 1.0 unit/mi in Krebs
Ringer bicarbonate, pH 7,4) or purified protease—free hep-
aritinase 124, 251 (0.1 mg/mI in Krebs Ringer bicarbonate
containing 0.01 xi acetate, pH 7.0). The perfusion fixative
solution included 2.5% glutaraldehyde in 0.1 M cacodylate
buffer, pH 7.4, either alone or containing 0.2% tannic acid to
enhance the visualization of immune complexes in the glomer-
ular extracellular matrices.
&i ___
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Fig. 3. Electron micrographs of glomeruli from
kidneys perfused with native complexes after
treatment with buffer (A), chondroitinase-ABC (B) or
heparitinase (C). The complexes are seen as large
electron—dense deposits (arrows) nonspecifically
lodged in the mesangium, and their localization is
unaffected by the enzymatic treatments.
Abbreviations are the same as Fig. 2 (x 12000).
Perfusion with immune complexes
A total of 112 rat kidneys (right) were perfused and utilized
for four sets of studies: immunofluorescence, electron micros-
copy, light and electron microscopic autoradiography, and
direct radiocounting of isolated glomeruli. Each set of studies
included 16 kidneys with four kidneys per variable, the four
variables being the two enzymes and their respective buffer
controls. The right renal artery was cannulated and the kidney
isolated from the systemic circulation. The kidney was then
flushed in situ with Krebs—Ringer bicarbonate albumin solution
followed by perfusion with chondroitinase-ABC (degrades
choadroitin sulfates ABC and hyaluronic acid) or heparitinase
(degrades heparan sulfate), or the corresponding oxygenated
control buffer solution at 37°C for 10 minutes. The kidneys were
then removed from the abdominal cavity, connected to an organ
perfusion system [26] and perfused with oxygenated
Krebs—Ringer bicarbonate albumin solution containing either
cationic or native immune complexes at 37°C for 20 minutes
following which the kidneys were flushed with 40 ml Krebs
Ringer bicarbonate albumin solution. Under these conditions,
heparitinase degrades the anionic sites of the GBM [25—271, and
viability is maintained by the criteria of retention of morpho-
logical integrity of glomerular structures and the ability to
incorporate sulfate into macromolecules in a linear fashion over
time [18, 19, 25].
Cap
i
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Characterization of binding of immune complexes
For immunofluorescence studies kidney slices were snap
frozen in chilled isopentane, 4 m cryostat sections made,
stained with fluoresceinated anti-rabbit IgG or anti-bovine IgG
and examined with an immunofluorescence microscope
equipped with epiillumination. For electron microscopic studies
the kidneys were fixed by perfusion with tannic acid—glutaral-
dehyde and processed [26].
Fig. 4. Light microscopic autoradio grams
of glomeruli obtained from kidneys
perfused with '251-labelled cationic (A,B,C)
or native (D,E,F) complexes after
treatment with buffer (A and D),
chondroitinase-ABC (B and E) or
heparitinase (C and F). Arrows indicate
the localization of cationic complexes in
the capillary walls (A,B) while circles
indicate their presence in the mesangium
(D—F). Note the marked decrement in
cationic complexes after heparitinase (C).
x 1,000.
For tissue autoradiography, 1 mm3 cortical pieces were cut
from perfused—fixed kidneys, osmicated, treated en bloc with
uranyl acetate, dehydrated, and embedded in EPON. Thick (0.5
m) and thin (600 A) sections were made and processed for light
and quantitative electron microscopic autoradiography [26, 27].
For quantitative autoradiography, 25 glomeruli from each group
were photographed at a magnification of x 600 and printed to a
final magnification of x 3,000. Capillary and mesangial com-
partments were defined, the grains associated with each corn-
S.-,:, -
- C A
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Fig. 5. Electron microscopic autoradiograms
of glomeruli from kidneys perfused with
1251-labelled cationic complexes after
treatment with buffer (A), chondroitinase-ABC
(B) or heparitinase (C). The majority of silver
grains are on the glomerular capillary walls
(arrows); they are diminished after treatment
with heparitinase (C). Abbreviations are the
same as Fig. 2. x 3,000.
partment were counted and the total area was computed by the
point counting method [27], utilizing a transparent overlay
network of points spaced 0.5 cm apart. The grain density was
computed by dividing total number of grains by total area
points. Finally, the mean grain density and standard deviation
were calculated.
For radiocounting of glomerular bound '251-immune com-
plexes, two kidneys for each variable (above) were perfused
and subsequently flushed with Krebs—Ringer bicarbonate albu-
min solution to remove unbound radioactivity. The cortices
were dissected free and frozen at —20°C overnight. The
glomeruli were then isolated by the sieving method [18, 26], and
radioactivity determined by gamma counter and expressed as
average counts per kidney.
Results
Immunofluorescent studies revealed similar patterns of stain-
ing of sections treated with either fluorescein—conjugated anti-
rabbit or anti-bovine IgG, that is, both components of the
immune complexes, for both the cationic and native complexes.
In control sections from kidneys perfused with cationic com-
plexes, a linear staining corresponding to glomerular and tubu-
lar basement membranes was observed (Fig. 1A). Slight mesan-
gial and interstitial staining was also present, and the vascular
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Table 1. Grain density distribution of radioiodinated cationic and
native immune complexes in different compartments of the
glomerulus with and without enzymatic treatments
Cationic complexes"
Capillary
Treatment wall Mesangium
Native complexes"
Capillary
wall Mesangium
Control 9.30 1.25 0.50 0.11 0.20 0.03 4.34 0.91
Chondroitinase- 9.33 0.96 0.45 0.05 0.20 0.02 4.37 0.48
ABC
Control 8.73 1.06 0.48 0.10 0.21 0.02 4.16 0.31
Heparitinase 0.03 0.01 0.02 0.01 0.20 0.01 3.96 0.48
Table 2. '251-associated radioactivity in isolated glomeruli from
kidneys perfused with cationic or native immune complexes with and
without enzymatic treatments
Cationic Native
Treatment complexes" Complexes"
Control 2,100 1,600
Chondroitinase-ABC 2,200 1,400
Control 1,900 1,700
Heparitinase 2 1,600
Each number is the average glomerular counts per minute per
kidney obtained from two kidneys (-9,500 glomeruli per kidney) x l0
Mean SD from 25 glomeruli from each group
basement membranes evidenced moderate reactivities with the
immune complexes as well. Prior chondroitinase-ABC treat-
ment did not change the pattern of immunofluorescent staining
(Fig. 1B). Treatment with heparitinase, however, abolished
binding of cationic immune complexes (Fig. IC) as indicated by
the lack of immunofluorescence of glomerular and tubular
basement membranes. Sections obtained from kidneys perfused
with more neutral native immune complexes revealed staining
primarily of the mesangium rather than the basement membrane
(Fig. ID). This mesangial staining was unaffected by treatment
with chondroitinase-ABC or heparitinase (Fig. 1 E, F).
Electron microscopic studies were carried out to determine
the precise localization of immune complexes in kidneys fixed
by tannic acid—glutaraldehyde perfusion. In a cross—section of
the glomerular capillary, the cationic complexes were visual-
ized as electron—dense deposits in the laminae rarae interna and
externa of the GBM (Fig. 2A), very much reminiscent of the
localization of anionic sites [41. The deposits were regularly
spaced at intervals of 600 A and exhibited a lattice—like network
in grazing sections of the basement membranes, The lattice—like
distribution could also be seen in the mesangial matrices as well
(Fig. 2B). Treatment with chondroitinase-ABC did not alter the
distribution of electron—dense deposits (Fig. 2B), whereas di-
gestion with heparitinase resulted in the loss of binding of
immune complexes and non-visualization of deposits in the
GBM and mesangial matrix (Fig. 2C). The more neutral native
complexes on the other hand seemed to be nonspecifically
lodged in the mesangial region, unaffected by the enzymatic
treatments, and with no specific relationship to glomerular
extracellular matrices (Fig. 3). Some complexes were seen in
the process of being phagocytosed by the monocyte—like cells in
the mesangium (Fig. 3B).
Tissue autoradiographic studies were performed to quantify
the distribution of immune complexes in various regions of the
glomerulus and to determine more accurately the enzymatic
effects on their localization. Similar to the immunolluorescent
findings, by light microscopy the radioiodinated cationic im-
mune complexes had a characteristic capillary distribution (Fig.
4A), unaffected by chondroitinase-ABC treatment (Fig. 4B),
but abolished by heparitinase digestion (Fig. 4C). The localiza-
tion of the native complexes was similar to what was observed
in earlier studies, namely mesangial, and unaffected by the
enzymes (Fig. 4D—F). Electron microscopic autoradiography
showed more precisely the differential localization of the
cationic immune complexes in the glomerular capillary wall
compared to the mesangium (Fig. 5A), with silver grain densi-
ties (concentration of radiation) of 9.30 1.25 and 0.50 0.11,
respectively (Table 1). No significant change in the grain
density distribution was observed after chondroitinase-ABC
treatment (Fig. 5B and Table 1), whereas heparitinase digestion
resulted in a remarkable reduction in both the glomerular
capillary wall and mesangium (Fig. 5C); grain densities were
0.03 0.01 and 0.02 0.01, respectively (Table 1). The grain
density distributions in kidneys perfused with native complexes
were 0.20 0.03 and 4.34 0.91 (chondroitinase buffer control)
in the capillary wall and mesangium, respectively, and no
statistically significant change was observed after enzymatic
treatments (Table I and Fig. 6).
Further confirmation of the binding characteristics of the
immune complexes was carried out by isolating glomeruli and
directly determining their radioactivity. Similar trends as ob-
served by immunofluorescence, electron microscopy, and tis-
sue autoradiography were noted (Table 2). The significant result
was the thousandfold reduction in binding of cationic com-
plexes after heparitinase treatment.
Discussion
Via immunofluorescent, electron microscopic, autoradio-
graphic, and direct counting techniques, converging evidence
has been obtained in this investigation that proteoglycans, that
is HS-PG, known to be integral components of glomerular
anionic sites, play a definitive role in the binding/deposition of
immune complexes with cationic charge. in contrast, the
proteoglycans do not seem to play a significant role in trapping
more neutral complexes. The multiple approaches were used in
an isolated organ perfusion system to arrive at concrete con-
clusions, which in previous investigations were somewhat
conjectural.
An cx vivo system was needed for a variety of reasons.
Firstly, the potential problem of in vivo dissociation of com-
plexes can be obviated adequately. Secondly, in this system
trapping/binding of immune complexes is studied independent
of humoral factors, such as complement. Thirdly, to ascertain
the role of proteoglycans in the binding of immune complexes,
molecular alterations have to be made in the proteoglycans.
This can be achieved in two ways, either by enzymatic diges-
tion whereby the glycosaminoglycan chains are degraded with
consequent disruption of the network of these highly charged
polymers [24], or by xyloside treatment, in which case the
carbohydrate chains are not transferred properly by the
xylosyltransferase for covalent attachment to the core protein
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Fig. 6. Electron microscopic autoradiograms
of glomeruli from kidneys perfused with
'251-labelled native complexes after treatment
with buffer (A), chondroitinase-ABC (B) or
heparitinase (C). The majority of the silver
grains are in the mesangium and their
distribution is unaffected by the enzymatic
treatments. Abbreviations are the same as
Fig. 2 (x 3,000).
with resultant abortive organization of the HS-PG molecule
[28]. Such xyloside treatment is ineffective in in vivo systems
because of its metabolic degradation, and weeks are required to
achieve alterations in the HS-PG macromolecular complex in
ex vivo and in vitro states. Hence, to address the issues of the
present investigation it was decided to employ enzymatic
treatment with ex vivo organ perfusion, a system that does not
seem to compromise the results obtained and conclusions
drawn in this or past investigations.
Proteoglycans, existing in extracellular matrices as large
macromolecules with lateral and/or end—to—end aggregation,
form a gel meshwork which is kept highly hydrated by water
molecules trapped in the interstices of the matrix [16, 29—31].
This matrix linked to other basement membrane components is
thought to give the GBM a viscous, gel—like consistency [32].
Such organization would promote or deter the binding of
immune complexes largely on an electrostatic basis and to a
lesser extent by virtue of steric entrapment. However, both
these effects of proteoglycans are more or less interwoven and
there is no ready means to study separately their roles in the
deposition of immune complexes. Nevertheless, the fact that
quantitative autoradiographic data indicate a negligible trapping
of more neutral complexes but exclusive deposition of cationic
complexes in the capillary wall or GBM suggests that it is
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mainly coulombic forces which are involved, in agreement with
previous work showing that intact immune complexes of mo-
lecular weight greater than one million can penetrate the GBM
if sufficiently cationic [81.
The available evidence thus strongly suggests that if immune
complexes carry sufficient positive charge, whether due to
antigen, antibody or both, they will bind to the sulfate groups of
the proteoglycans. In particular, the data presented here pro-
vide direct evidence that these negatively charged residues of
HS-PG are involved in such interactions. In previous studies
the significance of the net charge of the complex and the
respective contributions of antigen and antibody have been
debated. Nevertheless, the results obtained here reinforce the
concept that the charge of individual components of the com-
plex is less significant and that the net charge of the complex as
a whole is the important determinant of sites of reaction within
the glomerulus. These considerations are valid as long as the
immune complexes are not highly dissociable, and are soluble
and thus more easily diffusible. Previous results from our
laboratories [5, 81 indicate that the BGG-anti-BGG complexes
we have used, whether covalently linked or otherwise, have
identical distributions when administered intravenously. Simi-
larly, the fact that in the current studies the same unmodified
antibody was common to both the cationic and the more neutral
complexes and yet localized in different compartments of the
glomerulus argues that the complexes did not significantly
dissociate under the conditions used, and that it was the
antigens which ultimately influenced the net charge of the
complexes and their resultant patterns of deposition.
It now seems clear that immune complexes may entangle and
precipitate in a meshwork of proteoglycans primarily via elec-
trostatic forces. The present data certainly support such a
contention, originally proposed by Heilsing [33, 34]. The degree
to which these concepts apply to proteoglycans in human
kidneys and to human forms of immune complex nephropathy
remains to be determined. In this regard, it may be worth
considering that in the immune complexes employed in our
model system, the antibody was in its native state, and the
range of isoelectric points represented in the cationized BOG
antigen was comparable to that of a number of common
proteins including lysozyme, cytochrome C, histones, and
protamines, all of which have isoelectric points between 9.8 and
12.1 [351. It should also be kept in mind that because immune
complexes are heterogeneous, circulating complexes may not
be representative of the fraction which is most prone to cause
disease; in fact, it is possible that the complexes with the
greatest affinity for the GBM deposit so quickly that their
detection in serum becomes problematic.
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